Phoebe Rich, MD
Dermatology · Portland, ORNPI 1205818101
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Ortho Dermatologics, A Division Of Bausch Health US, LLC at 29.5% of the total. Reporting peaked in 2021 at $6,819 and has fallen 59.3% since, to $2,773 in 2025. Among dermatology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $234.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$5K
- Eli Lilly$4K
- LEO Pharma Inc.$3K
- LNHC, Inc$3K
- E.r. Squibb & Sons, L.L.C.$2K
- Johnson & Johnson$357
- plus $733 from 10 others
Across 1,327 payments — averaging $5635.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.7M
- Eli Lilly$1.4M
- UCB SA$1M
- Janssen Research & Development, LLC$744K
- Incyte Corporation$612K
- Novartis$507K
- plus $1.5M from 11 others
What the payments were for
- Consulting fees$9,02353%
- Speaking & faculty fees$2,60015%
- Travel & lodging$3,05218%
- Food & beverage$1,95911%
- Education$4903%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $5,053 |
| Eli Lilly | 26 | $3,767 |
| LEO Pharma Inc. | 5 | $2,909 |
| LNHC, Inc | 2 | $2,681 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,625 |
| Johnson & Johnson | 5 | $357 |
| Novartis | 4 | $305 |
| Janssen Scientific Affairs, LLC | 5 | $108 |
| AbbVie | 5 | $96 |
| Bristol Myers Squibb | 1 | $65 |
| Lilly USA, LLC | 4 | $58 |
| Sun Pharmaceutical Industries Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Galderma Laboratories, L.p. | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $19 |
| Pfizer | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,124 in reported general payments places this provider in the 90th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 17 | $1,054 |
| Terbinafine Hcl | 30 | $577 |
| CiclopiroxCiclopirox Olamine | 12 | $549 |
| Fluconazole | 26 | $270 |
| Triamcinolone Acetonide | 30 | $269 |
| Acyclovir | 16 | $243 |
| Ketoconazole | 12 | $201 |
| Minoxidil | 11 | $151 |
| Mupirocin | 12 | $87 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Portland
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
- Paul HaunPortland$85K
- Kathryn SchwarzenbergerPortland$34K
- Jon HanifinPortland$25K
- Tracy FunkPortland$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.